Wake Forest University Health Sciences

Part of Wake Forest University

CompanyUnited StatesFounded 2001

ROROpenAlexWikidata

Wake Forest University Health Sciences develops one asset, in phase 1 (Autologous tissue engineered corpora in corpora cavernosa; inflammation). Mostly cell therapy; based in the United States, founded in 2001.

1
Asset
Furthest stage
Phase 1
592
Grants
342
Trials
20
Signals

Pipeline

1
  • Autologous tissue engineered corpora

    Autologous endothelial and smooth muscle cells seed donor-derived scaffolds to reconstruct damaged penile tissues.

    Phase 1, Cell therapy, corpora cavernosa; inflammation, corpus callosum malformation

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials367
  • People24
  • Signals20
  • Similar companies6

Papers

Intelligence